Laura Bufkin
University of Mississippi Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Laura Bufkin.
British Journal of Obstetrics and Gynaecology | 2002
Everett F. Magann; Suneet P. Chauhan; Laura Bufkin; Karen Field; William E. Roberts; Martin Jn
Objective To determine whether the method used to expand the uterine incision for caesarean delivery affects the incidence of intra‐operative haemorrhage.
American Journal of Perinatology | 2011
Sharon Keiser; Michelle Y. Owens; Marc Parrish; Julie Cushman; Laura Bufkin; Warren L. May; James N. Martin
We assessed pregnancy outcomes for patients with HELLP syndrome (hemolysis; elevated liver enzymes; low platelet count) with and without concurrent eclampsia. We performed a retrospective investigation of data spanning three decades of patients with class 1 or 2 HELLP syndrome with concurrent eclampsia (HELLP + E) and patients with HELLP syndrome without eclampsia. Data were analyzed by appropriate tests for continuous or categorical outcomes with differences considered significant if P < 0.05. During 1981 to 1996 and 2000 to 2006, there were 693 patients with class 1 or 2 HELLP syndrome; altogether, 70 patients had HELLP + E. The only demographic difference was greater nulliparity in HELLP + E patients. Otherwise, inconsistent and clinically insignificant differences were observed between groups. Despite the relatively large size of the study groups, we were unable to detect a significant worsening of maternal or perinatal outcome in HELLP + E patients compared with HELLP patients. In our experience, eclampsia does not appear to contribute a significant adverse impact upon the course or outcome of HELLP syndrome pregnancies.
Obstetrics & Gynecology | 2005
P. Scott Barrilleaux; James N. Martin; Chad K. Klauser; Laura Bufkin; Warren L. May
OBJECTIVE: We compared maternal outcomes for patients with severe preeclampsia who were managed postpartum with or without adjunctive intravenous dexamethasone. METHODS: This study was a randomized, blinded placebo-controlled clinical trial comparing the use of dexamethasone postpartum (10 mg–10 mg–5 mg–5 mg intravenously every 12 hours) with a saline control in patients with severe preeclampsia. The Student t and &khgr;2 tests were used for data analysis, with P < .05 considered significant. RESULTS: Data from 157 patients (77 patients receiving dexamethasone, 80 patients receiving placebo) who were treated during 2000–2003 were analyzed. Demographics, diagnostic criteria, baseline laboratory values, and postpartum outcomes were similar between groups. Although dexamethasone-treated patients had fewer returns (6.5% compared with 11.3%) to the labor/delivery/recovery unit for uncontrolled hypertension than control patients, no significant differences were found in blood pressure, antihypertensive requirements, laboratory values, length of hospitalization, interval urine output at 48 hours postpartum, or major maternal morbidity. Two control patients developed hemolysis, elevated liver enzymes, low platelets syndrome. CONCLUSION: Adjunctive use of intravenous dexamethasone for postpartum patients with severe preeclampsia does not reduce disease severity or duration. LEVEL OF EVIDENCE: I
The Journal of Maternal-fetal Medicine | 2001
Everett F. Magann; Suneet P. Chauhan; J N Jr Martin; K. S. Bryant; Laura Bufkin; John C. Morrison
Objective: To compare two methods of uterine cleansing to remove residual amnion-chorion at the time of Cesarean delivery. Methods: All consenting uninfected parturients undergoing a non-emergency Cesarean delivery at the university were enrolled. All patients received antibiotic prophylaxis of a 1-g intravenous bolus of a first-generation cephalosporin immediately after cord clamping. Postpartum endometritis was defined as a temperature of S 100.4°F (38°C) on two occasions 6 h apart after the first 24 h with uterine tenderness and/or foul-smelling lochia. Results: Between January 1998 and February 2000 there were 1400 patients enrolled in this investigation. A total of 153 women were determined to have chorioamnionitis present at surgery and 17 women refused participation, leaving 614 women in the uterine wipe group and 616 in the no wipe group. Maternal demographics were similar between patient groups (NS). Intrapartum factors including gestational age at time of Cesarean section, type of anesthesia used for the operative delivery, hours of amnion rupture prior to delivery, use of internal monitoring devices, type of skin incision, method of placental removal, total operative time and estimated blood loss were similar between patient groups (NS). An almost identical number of patients in each arm of the study developed post-Cesarean endometritis (65 out of 614, 10.5%, in the uterine wipe group vs. 66 out of 616, 10.7%, in the no wipe group; p = 1). Conclusions: Both methods of removing residual amnion-chorion membrane tissue and associated debris at surgery were comparably effective, but neither produced a dramatic reduction in the incidence of postoperative endometritis.
American Journal of Perinatology | 2011
Kiran Tam Tam; Christian M. Briery; Alan D Penman; Laura Bufkin; James A. Bofill
We describe the epidemiological characteristics and identify maternal-fetal outcomes in pregnancies complicated by gastroschisis. We retrospectively reviewed 115 cases of gastroschisis at the University of Mississippi Medical Center. The incidence of gastroschisis trended upward between 2000 and 2008. Significant proportions of mothers were nonobese, nulliparous, teenagers, smokers, and nonconsumers of alcohol. Infants delivered at > 36 weeks or without sepsis had shorter hospital stay (HS) and interval to full enteral feeding (FEF). The rates of low birth weight (LBW), fetal growth restriction, and spontaneous preterm birth (PTB) were 63%, 45%, and 24%, respectively. Bowel atresia was noted in 9%. Rates of primary closure (25%), neonatal sepsis (29%), fetal death (2%), and infant mortality (4%) were notable. Median HS and interval to FEF were 40 and 30 days, respectively. The incidence of gastroschisis is increasing in Mississippi. Sepsis, LBW, and PTB are key determinants of poor infant outcomes.
American Journal of Obstetrics and Gynecology | 2005
Brad Thigpen; W. Ashley Hood; Suneet P. Chauhan; Laura Bufkin; James A. Bofill; Everett F. Magann; John C. Morrison
American Journal of Obstetrics and Gynecology | 2002
Everett F. Magann; Suneet P. Chauhan; Sheryl Rodts-Palenik; Laura Bufkin; James N. Martin; John C. Morrison
American Journal of Obstetrics and Gynecology | 2001
Brian K. Rinehart; Dom A. Terrone; Christy M. Isler; P. Scott Barrilleaux; Laura Bufkin; John C. Morrison
American Journal of Obstetrics and Gynecology | 2004
Brad Thigpen; James A. Bofill; Laura Bufkin; Thomas Woodring; Lisa Moore; John C. Morrison
American Journal of Obstetrics and Gynecology | 2003
P. Scott Barrilleaux; James N. Martin; Chad K. Klauser; Laura Bufkin; Warren L. May